Hi NextMan,

Thanks for the summary.

The full year expected figure does look "interesting" does it not. However the rns does say that the company is confident of meeting market expectations.

Although the atom probes are clearly big ticket items so difficult to predict sales they have sold some of the current version & I guess will need to sell more to meet this years expectations. The new version widening the market looks positive, and will clearly be needed to meet the 2006 market expectations.

I wonder if it might be better to try and value it as two companies, the atom probes part and the rest. If the rest can justify a PE of 15 (say) I wonder what PE this implies for the atom probes. As they don't appear to split out profits for the atom probes (not surprising I guess) this might be difficult. I may have a go when I have a little more time.

I hold

Deucetoace